Faculty Opinions recommendation of Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.
2017 ◽
Vol 15
(2)
◽
pp. 229-239.e5
◽
2020 ◽
Keyword(s):
2012 ◽
Vol 16
(1)
◽
pp. 107-109
◽